Seitarou Omoto

450 total citations
8 papers, 406 citations indexed

About

Seitarou Omoto is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Seitarou Omoto has authored 8 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Seitarou Omoto's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Protease and Inhibitor Mechanisms (2 papers). Seitarou Omoto is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Protease and Inhibitor Mechanisms (2 papers). Seitarou Omoto collaborates with scholars based in Japan and United States. Seitarou Omoto's co-authors include Shosaku� Nomura, Akira Shouzu, Toshiji Iwasaka, Mitsushige Nishikawa, Shirou Fukuhara, Norihito Inami, Yasuhiro Maeda, Fumiaki Urase, Yutaka Kimura and Nobuyuki Takahashi and has published in prestigious journals such as Thrombosis Research, Journal of Atherosclerosis and Thrombosis and Platelets.

In The Last Decade

Seitarou Omoto

8 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seitarou Omoto Japan 8 156 148 108 100 76 8 406
Channa Zhang China 15 150 1.0× 192 1.3× 63 0.6× 72 0.7× 81 1.1× 38 609
Makoto Hiramoto Japan 10 89 0.6× 88 0.6× 73 0.7× 102 1.0× 57 0.8× 14 400
Quanzhong Li China 13 139 0.9× 81 0.5× 65 0.6× 106 1.1× 70 0.9× 27 382
Inge A. M. van den Oever Netherlands 6 117 0.8× 99 0.7× 56 0.5× 47 0.5× 73 1.0× 7 479
Helena Grufman Sweden 11 232 1.5× 141 1.0× 109 1.0× 105 1.1× 173 2.3× 15 581
Berne Yee United States 10 219 1.4× 84 0.6× 83 0.8× 102 1.0× 72 0.9× 11 820
Eleonora Devangelio Italy 6 85 0.5× 109 0.7× 67 0.6× 50 0.5× 43 0.6× 6 387
Yisong Zhen China 16 282 1.8× 212 1.4× 44 0.4× 65 0.7× 35 0.5× 27 647
Jean C. Grégoire Canada 8 121 0.8× 211 1.4× 65 0.6× 207 2.1× 132 1.7× 14 505
R. Temaru Japan 9 91 0.6× 102 0.7× 221 2.0× 62 0.6× 101 1.3× 10 445

Countries citing papers authored by Seitarou Omoto

Since Specialization
Citations

This map shows the geographic impact of Seitarou Omoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seitarou Omoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seitarou Omoto more than expected).

Fields of papers citing papers by Seitarou Omoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seitarou Omoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seitarou Omoto. The network helps show where Seitarou Omoto may publish in the future.

Co-authorship network of co-authors of Seitarou Omoto

This figure shows the co-authorship network connecting the top 25 collaborators of Seitarou Omoto. A scholar is included among the top collaborators of Seitarou Omoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seitarou Omoto. Seitarou Omoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nomura, Shosaku�, Norihito Inami, Akira Shouzu, et al.. (2009). The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients. Platelets. 20(1). 16–22. 91 indexed citations
2.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2009). Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients. Blood Coagulation & Fibrinolysis. 20(6). 440–447. 25 indexed citations
3.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2009). Effects of Eicosapentaenoic Acid on Endothelial Cell-Derived Microparticles, Angiopoietins and Adiponectin in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 16(2). 83–90. 53 indexed citations
4.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2007). Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus. Thrombosis Research. 122(1). 39–45. 42 indexed citations
5.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2005). Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thrombosis Research. 117(4). 385–392. 79 indexed citations
6.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, Mitsushige Nishikawa, & Toshiji Iwasaka. (2005). 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes. Blood Coagulation & Fibrinolysis. 16(6). 423–428. 36 indexed citations
7.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2004). Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients. Journal of Thrombosis and Thrombolysis. 18(3). 177–185. 54 indexed citations
8.
Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, Mitsushige Nishikawa, & Toshiji Iwasaka. (2004). Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus. Thrombosis Research. 115(4). 277–285. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Channa Zhang Breakdown of academic impact, for papers by Makoto Hiramoto Breakdown of academic impact, for papers by Quanzhong Li Breakdown of academic impact, for papers by Inge A. M. van den Oever Breakdown of academic impact, for papers by Helena Grufman Breakdown of academic impact, for papers by Berne Yee Breakdown of academic impact, for papers by Eleonora Devangelio Breakdown of academic impact, for papers by Yisong Zhen Breakdown of academic impact, for papers by Jean C. Grégoire Breakdown of academic impact, for papers by R. Temaru
Rankless by CCL
2026